Physician_Profile_ID,Category,Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name,Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State,Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID,Total_Amount_of_Payment_USDollars,Date_of_Payment,Category,Record_ID
257156,GNRL,"Novartis Pharmaceuticals Corporation",NJ,100000000228,3880.00,02/22/2014,GNRL,152477728
257156,GNRL,"Janssen Products, LP",PA,100000000325,3500.00,11/02/2015,GNRL,267394504
257156,GNRL,"Alexion Pharmaceuticals, Inc.",CT,100000005462,1500.00,05/30/2014,GNRL,218586924
257156,GNRL,"Celgene Corporation",NJ,100000000343,1200.00,06/27/2014,GNRL,189914298
257156,GNRL,"Novartis Pharmaceuticals Corporation",NJ,100000000228,931.00,02/21/2014,GNRL,152477743
257156,GNRL,"Celgene Corporation",NJ,100000000343,562.74,05/02/2014,GNRL,189915530
257156,GNRL,"Alexion Pharmaceuticals, Inc.",CT,100000005462,478.40,05/29/2014,GNRL,218586920
257156,GNRL,"Janssen Products, LP",PA,100000000325,320.11,11/02/2015,GNRL,267394512
257156,GNRL,"Alexion Pharmaceuticals, Inc.",CT,100000005462,313.60,06/06/2014,GNRL,218586926
257156,GNRL,"Celgene Corporation",NJ,100000000343,301.40,05/02/2014,GNRL,189914280
257156,GNRL,"Novartis Pharmaceuticals Corporation",NJ,100000000228,281.96,02/22/2014,GNRL,152477723
257156,GNRL,"Alexion Pharmaceuticals, Inc.",CT,100000005462,243.00,05/30/2014,GNRL,218586922
257156,GNRL,"Janssen Scientific Affairs, LLC",NJ,100000000332,106.92,09/24/2013,GNRL,23917021
257156,GNRL,"Celgene Corporation",NJ,100000000343,105.50,05/02/2014,GNRL,189913302
257156,GNRL,"Amgen Inc.",CA,100000000203,99.00,11/30/2015,GNRL,297667013
257156,GNRL,"Astellas Pharma US Inc",IL,100000000137,94.99,11/20/2013,GNRL,111805338
257156,GNRL,"Astellas Pharma US Inc",IL,100000000137,85.00,07/11/2014,GNRL,168618808
257156,GNRL,"Janssen Products, LP",PA,100000000325,77.00,08/22/2013,GNRL,17399956
257156,GNRL,"Janssen Pharmaceuticals, Inc",NJ,100000000232,59.99,12/18/2013,GNRL,23817313
257156,GNRL,"Novartis Pharmaceuticals Corporation",NJ,100000000228,59.46,02/22/2014,GNRL,152477731
257156,GNRL,"Janssen Products, LP",PA,100000000325,50.00,11/02/2015,GNRL,267394531
257156,GNRL,"Celgene Corporation",NJ,100000000343,37.92,08/28/2013,GNRL,101791918
257156,GNRL,"Novartis Pharmaceuticals Corporation",NJ,100000000228,37.32,02/22/2014,GNRL,152477735
257156,GNRL,"Celgene Corporation",NJ,100000000343,36.16,05/02/2014,GNRL,189891166
257156,GNRL,"Janssen Products, LP",PA,100000000325,34.99,11/02/2015,GNRL,267394518
257156,GNRL,"E.R. Squibb & Sons, L.L.C.",NJ,100000005499,30.77,12/28/2015,GNRL,332496123
257156,GNRL,"Janssen Biotech, Inc.",PA,100000000329,25.77,04/02/2014,GNRL,156559212
257156,GNRL,"Amgen Inc.",CA,100000000203,23.63,02/16/2015,GNRL,297667010
257156,GNRL,"Celgene Corporation",NJ,100000000343,22.72,09/16/2014,GNRL,189846720
257156,GNRL,"Celgene Corporation",NJ,100000000343,22.61,02/18/2015,GNRL,328343783
257156,GNRL,"Grifols USA, LLC",CA,100000005420,22.60,08/21/2013,GNRL,30680917
257156,GNRL,"Celgene Corporation",NJ,100000000343,22.17,04/15/2015,GNRL,328514178
257156,GNRL,"Celgene Corporation",NJ,100000000343,21.63,09/22/2014,GNRL,189853954
257156,GNRL,"Janssen Biotech, Inc.",PA,100000000329,21.13,08/22/2013,GNRL,23870283
257156,GNRL,"NOVARTIS PHARMACEUTICALS CORPORATION",NJ,100000000228,20.86,12/10/2015,GNRL,263310728
257156,GNRL,"EISAI INC.",NJ,100000000136,20.79,01/27/2015,GNRL,337968722
257156,GNRL,"Novartis Pharmaceuticals Corporation",NJ,100000000228,20.74,08/07/2014,GNRL,152477766
257156,GNRL,"Novartis Pharmaceuticals Corporation",NJ,100000000228,20.40,05/06/2014,GNRL,152477754
257156,GNRL,"Novartis Pharmaceuticals Corporation",NJ,100000000228,20.40,12/02/2014,GNRL,152477762
257156,GNRL,"Celgene Corporation",NJ,100000000343,20.39,09/22/2015,GNRL,328424780
257156,GNRL,"Novartis Pharmaceuticals Corporation",NJ,100000000228,20.28,10/01/2014,GNRL,152477710
257156,GNRL,"NOVARTIS PHARMACEUTICALS CORPORATION",NJ,100000000228,19.30,01/28/2015,GNRL,263310754
257156,GNRL,"NOVARTIS PHARMACEUTICALS CORPORATION",NJ,100000000228,19.26,05/28/2015,GNRL,263310742
257156,GNRL,"Genentech USA, Inc.",CA,100000000226,19.26,02/05/2015,GNRL,317906050
257156,GNRL,"Medivation Inc.",CA,100000010858,19.15,02/26/2014,GNRL,221238380
257156,GNRL,"Eisai Inc.",NJ,100000000136,19.07,10/16/2013,GNRL,152501342
257156,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,18.91,12/23/2015,GNRL,290172156
257156,GNRL,"Janssen Biotech, Inc.",PA,100000000329,18.75,11/12/2015,GNRL,270224294
257156,GNRL,"Genentech USA, Inc.",CA,100000000226,18.48,02/09/2015,GNRL,318075490
257156,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,18.43,01/07/2015,GNRL,260069277
257156,GNRL,"Celgene Corporation",NJ,100000000343,18.23,07/21/2015,GNRL,328409384
257156,GNRL,"E.R. Squibb & Sons, L.L.C.",NJ,100000005499,17.95,01/16/2014,GNRL,187729822
257156,GNRL,"Novartis Pharmaceuticals Corporation",NJ,100000000228,17.57,01/29/2014,GNRL,152477748
257156,GNRL,"EISAI INC.",NJ,100000000136,17.11,04/21/2015,GNRL,338046988
257156,GNRL,"NOVARTIS PHARMACEUTICALS CORPORATION",NJ,100000000228,17.04,10/06/2015,GNRL,263310726
257156,GNRL,"NOVARTIS PHARMACEUTICALS CORPORATION",NJ,100000000228,16.73,10/21/2015,GNRL,263310732
257156,GNRL,"Novartis Pharmaceuticals Corporation",NJ,100000000228,16.66,12/17/2014,GNRL,152477714
257156,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,16.59,08/19/2015,GNRL,290172158
257156,GNRL,"Novartis Pharmaceuticals Corporation",NJ,100000000228,16.57,04/15/2014,GNRL,152477752
257156,GNRL,"Celgene Corporation",NJ,100000000343,16.57,03/25/2014,GNRL,189951536
257156,GNRL,"Alexion Pharmaceuticals, Inc.",CT,100000005462,16.30,02/05/2014,GNRL,218577852
257156,GNRL,"Janssen Biotech, Inc.",PA,100000000329,16.28,10/12/2015,GNRL,270224286
257156,GNRL,"Teva Pharmaceuticals USA, Inc.",PA,100000000141,16.21,09/19/2014,GNRL,173284028
257156,GNRL,"Teva Pharmaceuticals USA, Inc.",PA,100000000141,16.12,10/29/2015,GNRL,293839360
257156,GNRL,"Alexion Pharmaceuticals, Inc.",CT,100000005462,16.11,10/25/2013,GNRL,103204422
257156,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,15.94,05/08/2015,GNRL,260086192
257156,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,15.82,08/12/2013,GNRL,12099511
257156,GNRL,"Amgen Inc.",CA,100000000203,15.79,01/15/2014,GNRL,138171764
257156,GNRL,"Eisai Inc.",NJ,100000000136,15.79,11/06/2014,GNRL,184755308
257156,GNRL,"Celgene Corporation",NJ,100000000343,15.69,01/13/2015,GNRL,328306288
257156,GNRL,"E.R. Squibb & Sons, L.L.C.",NJ,100000005499,15.58,12/19/2013,GNRL,14021037
257156,GNRL,"Alexion Pharmaceuticals, Inc.",CT,100000005462,15.53,08/26/2015,GNRL,338115074
257156,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,15.43,11/20/2013,GNRL,12101004
257156,GNRL,"NOVARTIS PHARMACEUTICALS CORPORATION",NJ,100000000228,15.42,06/17/2015,GNRL,263310744
257156,GNRL,"Amgen Inc.",CA,100000000203,15.22,02/24/2014,GNRL,138171766
257156,GNRL,"Teva Pharmaceuticals USA, Inc.",PA,100000000141,15.22,06/01/2015,GNRL,293839358
257156,GNRL,"Janssen Products, LP",PA,100000000325,14.99,11/02/2015,GNRL,267394524
257156,GNRL,"Janssen Products, LP",PA,100000000325,14.99,11/02/2015,GNRL,267394538
257156,GNRL,"Teva Pharmaceuticals USA, Inc.",PA,100000000141,14.99,03/23/2015,GNRL,293839356
257156,GNRL,"AbbVie, Inc.",IL,100000000204,14.73,05/04/2015,GNRL,317464570
257156,GNRL,"E.R. Squibb & Sons, L.L.C.",NJ,100000005499,14.65,05/06/2015,GNRL,331671583
257156,GNRL,"E.R. Squibb & Sons, L.L.C.",NJ,100000005499,14.65,08/31/2015,GNRL,331923211
257156,GNRL,"Amgen Inc.",CA,100000000203,14.47,11/24/2014,GNRL,138171768
257156,GNRL,"EISAI INC.",NJ,100000000136,14.47,11/20/2015,GNRL,337967090
257156,GNRL,"E.R. Squibb & Sons, L.L.C.",NJ,100000005499,14.41,02/19/2015,GNRL,331543249
257156,GNRL,"E.R. Squibb & Sons, L.L.C.",NJ,100000005499,14.35,01/29/2015,GNRL,332315659
257156,GNRL,"SANOFI-AVENTIS U.S. LLC",NJ,100000000076,14.32,02/11/2015,GNRL,319153847
257156,GNRL,"Incyte Corporation",DE,100000000263,14.31,01/15/2015,GNRL,298502858
257156,GNRL,"Merck Sharp & Dohme Corporation",NJ,100000000053,14.25,05/30/2014,GNRL,201776450
257156,GNRL,"Merck Sharp & Dohme Corporation",NJ,100000000053,14.15,02/10/2015,GNRL,330173735
257156,GNRL,"Merck Sharp & Dohme Corporation",NJ,100000000053,13.91,10/21/2014,GNRL,202251860
257156,GNRL,"E.R. Squibb & Sons, L.L.C.",NJ,100000005499,13.84,06/16/2015,GNRL,331690779
257156,GNRL,"SANOFI-AVENTIS U.S. LLC",NJ,100000000076,13.82,11/04/2014,GNRL,188839448
257156,GNRL,"Medivation Inc.",CA,100000010858,13.67,04/27/2015,GNRL,339303764
257156,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,13.38,03/30/2015,GNRL,290172160
257156,GNRL,"Janssen Biotech, Inc.",PA,100000000329,13.35,09/09/2014,GNRL,156559214
257156,GNRL,"Amgen Inc.",CA,100000000203,13.24,03/26/2015,GNRL,297667006
257156,GNRL,"Novartis Pharmaceuticals Corporation",NJ,100000000228,13.20,03/06/2014,GNRL,152477786
257156,GNRL,"NOVARTIS PHARMACEUTICALS CORPORATION",NJ,100000000228,13.07,09/01/2015,GNRL,263310738
257156,GNRL,"Genentech USA, Inc.",CA,100000000226,13.07,03/09/2015,GNRL,317854032
257156,GNRL,"SANOFI-AVENTIS U.S. LLC",NJ,100000000076,12.97,09/10/2015,GNRL,319837052
257156,GNRL,"Bayer HealthCare Pharmaceuticals Inc.",NJ,100000005467,12.92,12/08/2015,GNRL,337914688
257156,GNRL,"Genentech USA, Inc.",CA,100000000226,12.91,04/21/2015,GNRL,318077106
257156,GNRL,"GENZYME CORPORATION",MA,100000000297,12.80,10/07/2014,GNRL,188883446
257156,GNRL,"Genentech USA, Inc.",CA,100000000226,12.75,06/08/2015,GNRL,317854042
257156,GNRL,"E.R. Squibb & Sons, L.L.C.",NJ,100000005499,12.73,09/08/2015,GNRL,331960413
257156,GNRL,"LILLY USA, LLC",IN,100000000066,12.72,09/19/2013,GNRL,4765410
257156,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,12.59,04/02/2015,GNRL,260098228
257156,GNRL,"Alexion Pharmaceuticals, Inc.",CT,100000005462,12.58,08/28/2014,GNRL,218594602
257156,GNRL,"Spectrum Pharmaceuticals Inc.",NV,100000011115,12.58,11/16/2015,GNRL,340700204
257156,GNRL,"Astellas Pharma US Inc",IL,100000000137,12.55,08/12/2015,GNRL,294748258
257156,GNRL,"Janssen Pharmaceuticals, Inc",NJ,100000000232,12.48,09/25/2015,GNRL,275512522
257156,GNRL,"NOVARTIS PHARMACEUTICALS CORPORATION",NJ,100000000228,12.48,11/10/2015,GNRL,263310730
257156,GNRL,"Teva Pharmaceuticals USA, Inc.",PA,100000000141,12.40,11/25/2013,GNRL,21837724
257156,GNRL,"Lilly USA, LLC",IN,100000000066,12.38,12/01/2015,GNRL,268023822
257156,GNRL,"Medivation Inc.",CA,100000010858,12.23,11/17/2014,GNRL,221251270
257156,GNRL,"Lilly USA, LLC",IN,100000000066,12.18,05/21/2015,GNRL,268023818
257156,GNRL,"Incyte Corporation",DE,100000000263,12.04,10/16/2014,GNRL,164165298
257156,GNRL,"SANOFI-AVENTIS U.S. LLC",NJ,100000000076,12.01,12/15/2015,GNRL,319798840
257156,GNRL,"NOVARTIS PHARMACEUTICALS CORPORATION",NJ,100000000228,11.95,04/22/2015,GNRL,263310746
257156,GNRL,"Bayer HealthCare Pharmaceuticals Inc.",NJ,100000005467,11.92,06/30/2015,GNRL,337903762
257156,GNRL,"Incyte Corporation",DE,100000000263,11.91,11/18/2013,GNRL,100005636
257156,GNRL,"Eisai Inc.",NJ,100000000136,11.78,04/24/2014,GNRL,184763232
257156,GNRL,"SANOFI-AVENTIS U.S. LLC",NJ,100000000076,11.72,05/20/2014,GNRL,188618372
257156,GNRL,"Novartis Pharmaceuticals Corporation",NJ,100000000228,11.68,03/23/2014,GNRL,152477703
257156,GNRL,"SANOFI-AVENTIS U.S. LLC",NJ,100000000076,11.67,10/23/2013,GNRL,14269814
257156,GNRL,"Emergent BioSolutions Inc.",MD,100000011074,11.65,09/05/2013,GNRL,31887318
257156,GNRL,"Genentech USA, Inc.",CA,100000000226,11.64,12/18/2014,GNRL,208283146
257156,GNRL,"Teva Pharmaceuticals USA, Inc.",PA,100000000141,11.48,09/11/2013,GNRL,21837723
257156,GNRL,"Merck Sharp & Dohme Corporation",NJ,100000000053,11.34,06/15/2015,GNRL,330637071
257156,GNRL,"Novartis Pharmaceuticals Corporation",NJ,100000000228,11.29,05/21/2014,GNRL,152477706
257156,GNRL,"SANOFI-AVENTIS U.S. LLC",NJ,100000000076,11.19,05/19/2015,GNRL,319669620
257156,GNRL,"Prometheus Laboratories Inc.",CA,100000010425,11.15,10/10/2013,GNRL,219518880
257156,GNRL,"LILLY USA, LLC",IN,100000000066,11.14,05/19/2014,GNRL,137724588
257156,GNRL,"Janssen Pharmaceuticals, Inc",NJ,100000000232,11.11,11/13/2013,GNRL,23817314
257156,GNRL,"Daiichi Sankyo Inc.",NJ,100000000195,10.99,04/30/2015,GNRL,326101766
257156,GNRL,"Daiichi Sankyo Inc.",NJ,100000000195,10.98,12/01/2015,GNRL,326275600
257156,GNRL,"Lilly USA, LLC",IN,100000000066,10.86,08/26/2015,GNRL,268023820
257156,GNRL,"Astellas Pharma US Inc",IL,100000000137,10.85,03/16/2015,GNRL,295235740
257156,GNRL,"LILLY USA, LLC",IN,100000000066,10.79,02/18/2014,GNRL,137897988
257156,GNRL,"SANOFI-AVENTIS U.S. LLC",NJ,100000000076,10.71,08/07/2013,GNRL,14257650
257156,GNRL,"E.R. Squibb & Sons, L.L.C.",NJ,100000005499,10.69,10/09/2013,GNRL,14021036
257156,GNRL,"Incyte Corporation",DE,100000000263,10.66,08/18/2015,GNRL,298502860
257156,GNRL,"Eisai Inc.",NJ,100000000136,10.64,02/11/2014,GNRL,184775590
257156,GNRL,"Novartis Pharmaceuticals Corporation",NJ,100000000228,10.64,09/24/2014,GNRL,152477770
257156,GNRL,"SANOFI-AVENTIS U.S. LLC",NJ,100000000076,10.63,08/20/2014,GNRL,188753866
257156,GNRL,"Amgen Inc.",CA,100000000203,10.59,12/16/2013,GNRL,8973578
257156,GNRL,"Merck Sharp & Dohme Corporation",NJ,100000000053,10.50,04/28/2014,GNRL,201522482
257156,GNRL,"Novartis Pharmaceuticals Corporation",NJ,100000000228,10.46,08/26/2014,GNRL,152477778
257156,GNRL,"Amgen Inc.",CA,100000000203,10.41,10/29/2013,GNRL,8973579
257156,GNRL,"Bayer HealthCare Pharmaceuticals Inc.",NJ,100000005467,10.37,03/02/2015,GNRL,337913302
257156,GNRL,"Celgene Corporation",NJ,100000000343,10.35,12/11/2014,GNRL,189877674
257156,GNRL,"Merck Sharp & Dohme Corporation",NJ,100000000053,10.29,02/03/2014,GNRL,201045914
257156,GNRL,"E.R. Squibb & Sons, L.L.C.",NJ,100000005499,10.08,12/02/2015,GNRL,332237705
257156,GNRL,"E.R. Squibb & Sons, L.L.C.",NJ,100000005499,10.03,11/05/2015,GNRL,332125187
257156,GNRL,"Novartis Pharmaceuticals Corporation",NJ,100000000228,10.02,08/21/2014,GNRL,152477718
257156,GNRL,"Novartis Pharmaceuticals Corporation",NJ,100000000228,10.00,02/22/2014,GNRL,152477739
257156,GNRL,"NOVARTIS PHARMACEUTICALS CORPORATION",NJ,100000000228,9.95,09/02/2015,GNRL,263310736
257156,GNRL,"NOVARTIS PHARMACEUTICALS CORPORATION",NJ,100000000228,9.87,01/27/2015,GNRL,263310752
257156,GNRL,"Amgen Inc.",CA,100000000203,9.38,08/06/2015,GNRL,297924386
257156,GNRL,"Luitpold Pharmaceuticals Inc",NY,100000010540,9.26,05/22/2014,GNRL,172031598
257156,GNRL,"Astellas Pharma US Inc",IL,100000000137,9.20,08/20/2013,GNRL,111793690
257156,GNRL,"Astellas Pharma US Inc",IL,100000000137,8.70,12/12/2013,GNRL,111750248
257156,GNRL,"Astellas Pharma US Inc",IL,100000000137,8.68,01/30/2014,GNRL,168742172
257156,GNRL,"NOVARTIS PHARMACEUTICALS CORPORATION",NJ,100000000228,8.62,05/05/2015,GNRL,263310748
257156,GNRL,"Astellas Pharma US Inc",IL,100000000137,8.42,05/27/2014,GNRL,168867766
257156,GNRL,"NOVARTIS PHARMACEUTICALS CORPORATION",NJ,100000000228,8.22,06/02/2015,GNRL,263310740
257156,GNRL,"Astellas Pharma US Inc",IL,100000000137,7.94,08/20/2013,GNRL,111810804
257156,GNRL,"Astellas Pharma US Inc",IL,100000000137,7.83,09/17/2014,GNRL,168828526
257156,GNRL,"Novartis Pharmaceuticals Corporation",NJ,100000000228,7.80,03/24/2014,GNRL,152477694
257156,GNRL,"Astellas Pharma US Inc",IL,100000000137,7.79,10/31/2013,GNRL,111737192
257156,GNRL,"NOVARTIS PHARMACEUTICALS CORPORATION",NJ,100000000228,7.70,03/03/2015,GNRL,263310750
257156,GNRL,"Novartis Pharmaceuticals Corporation",NJ,100000000228,7.64,11/20/2014,GNRL,152477774
257156,GNRL,"Astellas Pharma US Inc",IL,100000000137,7.36,08/18/2014,GNRL,168864730
257156,GNRL,"Celgene Corporation",NJ,100000000343,7.24,07/15/2015,GNRL,328424030
257156,GNRL,"Celgene Corporation",NJ,100000000343,6.79,03/25/2015,GNRL,328339450
257156,GNRL,"Celgene Corporation",NJ,100000000343,6.68,07/15/2015,GNRL,328390010
257156,GNRL,"NOVARTIS PHARMACEUTICALS CORPORATION",NJ,100000000228,6.55,10/20/2015,GNRL,263310734
257156,GNRL,"Novartis Pharmaceuticals Corporation",NJ,100000000228,6.39,10/17/2014,GNRL,152477758
257156,GNRL,"Janssen Biotech, Inc.",PA,100000000329,6.08,11/19/2015,GNRL,270224278
257156,GNRL,"Janssen Pharmaceuticals, Inc",NJ,100000000232,6.06,08/04/2015,GNRL,275512518
257156,GNRL,"Janssen Pharmaceuticals, Inc",NJ,100000000232,6.06,09/24/2015,GNRL,275512520
257156,GNRL,"Janssen Biotech, Inc.",PA,100000000329,5.54,09/16/2015,GNRL,270224282
257156,GNRL,"Astellas Pharma US Inc",IL,100000000137,5.51,04/07/2014,GNRL,168524590
257156,GNRL,"Celgene Corporation",NJ,100000000343,4.78,03/25/2014,GNRL,189882388
257156,GNRL,"E.R. Squibb & Sons, L.L.C.",NJ,100000005499,4.41,02/02/2015,GNRL,331473093
257156,GNRL,"Janssen Biotech, Inc.",PA,100000000329,4.24,11/03/2015,GNRL,270224274
257156,GNRL,"Janssen Biotech, Inc.",PA,100000000329,3.70,10/12/2015,GNRL,270224290
257156,GNRL,"Novartis Pharmaceuticals Corporation",NJ,100000000228,3.57,01/28/2014,GNRL,152477782
257156,GNRL,"Celgene Corporation",NJ,100000000343,1.70,03/25/2015,GNRL,328339448
257156,GNRL,"E.R. Squibb & Sons, L.L.C.",NJ,100000005499,1.69,02/19/2015,GNRL,331543245
257156,GNRL,"LILLY USA, LLC",IN,100000000066,1.59,09/18/2013,GNRL,4768761
257156,GNRL,"E.R. Squibb & Sons, L.L.C.",NJ,100000005499,1.43,12/02/2015,GNRL,332237717
257156,GNRL,"Janssen Biotech, Inc.",PA,100000000329,1.29,11/03/2015,GNRL,270224270
257156,GNRL,"E.R. Squibb & Sons, L.L.C.",NJ,100000005499,1.11,05/06/2015,GNRL,331671579
257156,GNRL,"Celgene Corporation",NJ,100000000343,1.00,07/15/2015,GNRL,328394532
257156,GNRL,"Celgene Corporation",NJ,100000000343,0.99,12/10/2014,GNRL,189871560
257156,GNRL,"Novartis Pharmaceuticals Corporation",NJ,100000000228,0.68,06/23/2014,GNRL,152477700
257156,GNRL,"E.R. Squibb & Sons, L.L.C.",NJ,100000005499,0.57,12/02/2015,GNRL,332237729
257156,GNRL,"E.R. Squibb & Sons, L.L.C.",NJ,100000005499,0.53,02/19/2015,GNRL,331543247
257156,GNRL,"Astellas Pharma US Inc",IL,100000000137,0.52,08/18/2014,GNRL,168735046
